Keystone Symposia

This meeting took place in 2020


Here are the related meetings in 2021:
Plant Genome Engineering: From Lab to Field (EK25)
Precision Engineering of the Genome, Epigenome and Transcriptome (EK24)

For a complete list of the meetings for the upcoming/current season, see our meeting list, or search for a meeting.

Engineering the Genome (Q2)


Organizer(s) Vic Myer and Erik Sontheimer
February 8—12, 2020
Fairmont Banff Springs • Banff, AB Canada
Discounted Abstract Deadline: Oct 29, 2019
Abstract Deadline: Nov 6, 2019
Scholarship Deadline: Oct 29, 2019
Discounted Registration Deadline: Dec 10, 2019

Sponsored by Editas Medicine and Novo Nordisk A/S


Summary of Meeting:
Genome editing is already transforming biological science and promises to do the same for human medicine. Technological capabilities are advancing rapidly and there are expected to be more than 30 genome editing therapies in clinical development by 2020. It is therefore important that practitioners in both academia and industry have the opportunity to learn about the latest improvements and applications. This conference will bridge that gap and provide an ideal environment for scientific exchange. In addition, participants will be educated on the growing roster and utility of genome engineering platforms. There will be sessions on genome editing’s clinical advancements and the evolution of thinking in the field regarding translational sciences. This meeting is being paired with Emerging Cellular Therapies so that participants can come together with researchers who focus on cell-based therapies. Therefore, we anticipate attendees will have a greater awareness of the full range of genome engineering tools, both established and emerging and knowledge of best practices and pitfalls in clinical advancement.

View Meeting Program

Scholarships/Awards


National Center for Advancing Translational Sciences (NCATS)/Office of the Director (OD) Scholarship Recipients


Tatiana Blanchard
University of Pennsylvania, USA

Tiffany Carlaw
University of British Columbia, Canada

Hannah N. De Jong
Stanford University, USA

Danielle Nicole Gallagher
Brandeis University, USA

Jennifer R. Hamilton
University of California, Berkeley, USA

Sarah Laura Krausz
Institute of Enzymology, Research Center for Natural Sciences, Hungary

Avery J. Lam
University of British Columbia, Canada

Barbara Mair
University of Toronto, Canada

Shannon Miller
Harvard University, USA

Theodore Roth
University of California, San Francisco, USA

Shady Sayed
German Cancer Research Center, Germany

Emmanouela Tsagkaraki
University of Massachusetts Medical School, USA

Nicole Vo
University of Washington, USA

Yvon Woappi
Brigham and Women's Hospital, USA